Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland

被引:38
作者
Allen, Elizabeth J. [2 ]
Palmateer, Norah E. [1 ]
Hutchinson, Sharon J. [1 ,3 ]
Cameron, Sheila [4 ]
Goldberg, David J. [1 ]
Taylor, Avril [2 ]
机构
[1] Hlth Protect Scotland, Glasgow G2 6QE, Lanark, Scotland
[2] Univ W Scotland, Inst Appl Social & Hlth Res, Sch Social Sci, Paisley PA1 2BE, Renfrew, Scotland
[3] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland
[4] Gartnavel Royal Hosp, W Scotland Specialist Virol Ctr, Glasgow G12 0YN, Lanark, Scotland
关键词
Hepatitis C virus; Injection equipment; Methadone; Recent infection; DRIED BLOOD SPOTS; HUMAN-IMMUNODEFICIENCY-VIRUS; SECONDARY EXCHANGE; RISK BEHAVIORS; USERS; PREVALENCE; HIV; COHORT; AUSTRALIA; PROVISION;
D O I
10.1016/j.drugpo.2012.07.006
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Prevalence of the hepatitis C virus (HCV) among people who inject drugs (PWID) in Scotland is high. The Scottish Government has invested significantly in harm reduction interventions with the goal of reducing HCV transmission among PWID. In evaluating the effectiveness of interventions, estimates of HCV incidence are essential. Methods: During 2008-2009, PWID were recruited from services providing sterile injecting equipment across mainland Scotland, completed an interviewer-administered questionnaire and provided a dried blood spot for anonymous anti-HCV and HCV-RNA testing. Recent infections were defined as anti-HCV negative and HCV-RNA positive. Logistic regression was undertaken to examine associations between recent HCV infection and self-reported uptake of methadone maintenance therapy (MMT) and injection equipment. Results: Fifty-four percent (1367/2555) of participants were anti-HCV positive. We detected 24 recent HCV infections, yielding incidence rate estimates ranging from 10.8 to 21.9 per 100 person-years. After adjustment for confounders, those with high needle/syringe coverage had reduced odds of recent infection (adjusted odds ratio [AOR]0.32,95% CI 0.10-1.00, p = 0.050). In the Greater Glasgow & Clyde region only, we observed a reduced odds of recent infection among those currently receiving MMT. relative to those on MMT in the last six months but not currently (AOR 0.04,95% CI 0.001-1.07, p = 0.055). The effect of combined uptake of MMT and high needle/syringe coverage was only significant in unadjusted analyses (OR 0.34,95% CI 0.12-0.97, p = 0.043; AOR 0.48,95% CI 0.16-1.48, p = 0.203). Conclusion: We report the first large-scale, national application of a novel method designed to determine incidence of HCV among PWID using a cross-sectional design. Subsequent sweeps of this survey will increase statistical power and allow us to gauge the impact of preventive interventions. (C) 2012 Elsevier B.V. All rights reserved,
引用
收藏
页码:346 / 352
页数:7
相关论文
共 33 条
[1]   At-Risk Drinking and Injection and Sexual Risk Behaviors of HIV-Positive Injection Drug Users Entering Drug Treatment in New York City [J].
Arasteh, Kamyar ;
Jarlais, Don C. Des .
AIDS PATIENT CARE AND STDS, 2009, 23 (08) :657-661
[2]   Detection of hepatitis C virus RNA in dried blood spots [J].
Bennett, Susan ;
Gunson, Rory N. ;
McAllister, Georgina E. ;
Hutchinson, Sharon J. ;
Goldberg, David J. ;
Cameron, Sheila O. ;
Carman, William F. .
JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (02) :106-109
[3]   Secondary exchange of sterile injecting equipment in a high distribution environment: A mixed method analysis in south east Sydney, Australia [J].
Bryant, Joanne ;
Hopwood, Max .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2009, 20 (04) :324-328
[4]   Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: A cohort study [J].
Champion, JK ;
Taylor, A ;
Hutchinson, S ;
Cameron, S ;
McMenamin, J ;
Mitchell, A ;
Goldberg, D .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (05) :514-519
[5]   Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size [J].
Craine, N. ;
Hickman, M. ;
Parry, J. V. ;
Smith, J. ;
Walker, A. M. ;
Russell, D. ;
Nix, B. ;
May, M. ;
McDonald, T. ;
Lyons, M. .
EPIDEMIOLOGY AND INFECTION, 2009, 137 (09) :1255-1265
[6]  
European Centre for Disease Prevention and Control, 2011, EV EFF INT PREV PE 1
[7]   Dynamics of viremia in early hepatitis C virus infection [J].
Glynn, SA ;
Wright, DJ ;
Kleinman, SH ;
Hirschkorn, D ;
Tu, Y ;
Heldebrant, C ;
Smith, R ;
Giachetti, C ;
Gallarda, J ;
Busch, MP .
TRANSFUSION, 2005, 45 (06) :994-1002
[8]  
Health Protection Scotland and University of the West of Scotland, 2008, NEEDL EXCH SURV IN N
[9]   Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots [J].
Hope, V. D. ;
Hickman, M. ;
Ngui, S. L. ;
Jones, S. ;
Telfer, M. ;
Bizzarri, M. ;
Ncube, F. ;
Parry, J. V. .
JOURNAL OF VIRAL HEPATITIS, 2011, 18 (04) :262-270
[10]   Prevalence of hepatitis C among injectors in Scotland 1989-2000: declining trends among young injectors halt in the late 1990s [J].
Hutchinson, SJ ;
McIntyre, PG ;
Molyneaux, P ;
Cameron, S ;
Burns, S ;
Taylor, A ;
Goldberg, DJ .
EPIDEMIOLOGY AND INFECTION, 2002, 128 (03) :473-477